THE EXPENDITURE AND REIMBURSEMENT OF ORPHAN DRUG IN TAIWAN: CHALLENGES AND OPPORTUNITIES

被引：0
|
作者：
Chiang, P. [1 ]
Yang, W. [1 ]
机构：
[1] Ctr Drug Evaluat, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1021
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY82
引用
收藏
页码：A255 / A255
页数：1
相关论文
共 50 条
  • [1] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN
    Cheng, C. Y.
    Chan, H. W.
    Fang, C. H.
    [J]. VALUE IN HEALTH, 2019, 22 : S856 - S856
  • [2] Orphan drug development in China - Turning challenges into opportunities
    Jin, Xiaowei
    Chen, Li
    [J]. INTRACTABLE & RARE DISEASES RESEARCH, 2016, 5 (04) : 308 - 313
  • [3] INTERNATIONAL COMPARISON OF ORPHAN DRUG POLICY EFFECT ON ORPHAN DRUG EXPENDITURE
    Kang, D.
    Choi, S. E.
    Shin, G. S.
    Bae, E.
    Lim, E. A.
    [J]. VALUE IN HEALTH, 2019, 22 : S605 - S605
  • [4] Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective
    Rosann Reinhart
    Krysten Madrzjewski
    [J]. Drug information journal : DIJ / Drug Information Association, 2010, 44 : 101 - 109
  • [5] Opportunities and challenges in drug discovery targeting the orphan receptor GPR12
    Wang, Pingyuan
    Lv, Ling
    Li, Haoran
    Wang, Chang-Yun
    Zhou, Jia
    [J]. DRUG DISCOVERY TODAY, 2023, 28 (09)
  • [6] Orphan Drug Development: Opportunities and Challenges from a Midsized to Large Company Perspective
    Reinhart, Rosonn
    Modrzjewski, Krysten
    [J]. DRUG INFORMATION JOURNAL, 2010, 44 (02): : 101 - 109
  • [7] Orphan drug development: The impact of regulatory and reimbursement frameworks
    Huang, Yu-Jun
    Chao, Wan-Yu
    Wang, Chi-Chuan
    Chang, Lin-Chau
    [J]. DRUG DISCOVERY TODAY, 2022, 27 (06) : 1724 - 1732
  • [8] Orphan Drug Pricing and Reimbursement Policies Lacking in EU
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 297 - 298
  • [9] ORPHAN DRUG REIMBURSEMENT IN ENGLAND AND IMPLICATIONS FOR PATIENT ACCESS
    Walker, S.
    Lilley, H.
    Payne, R.
    Fountain, D.
    [J]. VALUE IN HEALTH, 2019, 22 : S859 - S859
  • [10] A systematic review of moral reasons on orphan drug reimbursement
    Zimmermann, Bettina M.
    Eichinger, Johanna
    Baumgartner, Matthias R.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
12345